A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, +47

Nature Medicine

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz, +41

The Lancet Oncology

HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation

Ravindra K. Gupta, Sultan Abdul-Jawad, Laura E. McCoy, +21

Nature

TransplantationHuman RetrovirusStem Cell TransplantationImmunologyHematology +5

The soluble isoform of CTLA‐4 as a regulator of T‐cell responses

Frank J. Ward, Lekh N. Dahal, Subadra K. Wijesekera, +5

European Journal of Immunology

Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients

Sultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai, +48

Cancer Cell

Their LegaciesViral PersistenceViral DiagnosticsRespiratory DiseasesImmunology +8

Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection

Beatrice Ondondo, Hayato Murakoshi, Genevieve Clutton, +8

Molecular Therapy

Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, +47

Nature Medicine

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz, +37

ImmunologyCancer PatientsVaccine HesitancyImmunotherapyCovid-19 +17

Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition

Sultan Abdul-Jawad, Beatrice Ondondo, Andy van Hateren, +4

Molecular Therapy

Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells

Nicola Ternette, Peter D. Block, Álvaro Sánchez-Bernabéu, +8

Journal of Virology